Prosperico Ventures

Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity.

KingstronBio manufactures artificial heart valves and annuloplasty rings.

Singlera Genomics is a fast growing company focusing on non-invasive genetic testing. Singlera’s main products and services include tumor diagnosis and personalized treatment, non-invasive prenatal diagnosis, pre-implantation genetic screening, and customized scientific research services. Singlera is dedicated to the development of precision medicine, striving to help the patients through early, accurate and informative diagnoses.

Silexon is an AI drug research and development service provider. It is committed to the systematic integration of drug big data using artificial intelligence methods, and deep-enhanced drug development process, specifically involving drug target panorama report, personalized cell therapy, and small molecule virtual screening.

Its main business scope is medical device technology development and sales; biomedical technology development, technology transfer, technical consulting services; corporate marketing planning; market research; business information consulting; Management consulting services; self-operated and agent import and export business of various commodities and technologies.

Infinovo was formed in 2016. For the past several years, Infinovo has been focusing on developing an accurate and affordable CGM (Continuous Glucose Monitoring) for patients which will be available for both Type 1 and Type 2 Diabeties. The company has developed a CGM which can compete in the global market for accuracy, durability, and design.

Wolfman Medical Technology is a medical imaging equipment developer dedicated to medical imaging technology and brain

Xynomic Pharma focuses on in-licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. The founding executives worked at leading multinational biopharmaceutical companies (Schering, Eli Lilly, Merck, and Roche) in R&D roles. The founders also had successful entrepreneurial experiences including founding, building, and exiting successful US-China biopharmaceutical companies.Xynomic Pharma aims to build a comprehensive clinical and pre-clinical stage oncology pipeline targeting cancers with high prevalence in China, US and rest of the world. Xynomic Pharma leverages global resources, enabling the company to develop drugs in a cost and time-efficient manner.

Singlera Genomics is a fast growing company focusing on non-invasive genetic testing. Singlera’s main products and services include tumor diagnosis and personalized treatment, non-invasive prenatal diagnosis, pre-implantation genetic screening, and customized scientific research services. Singlera is dedicated to the development of precision medicine, striving to help the patients through early, accurate and informative diagnoses.

Fourier Intelligence is a Shanghai-based technology and design company providing exoskeleton robotic product and service on rehabilitation & orthoses. Its products include upper-limb rehab robotics and lower-limb exoskeleton robot, which can help the disabled go beyond of the physical limits, stand up and walk again. Its exoskeleton products can also decrease fatigue and increase productivity whilst unloading supplies or enabling workers/soldiers to carry heavy objects.

Chao Ju Ophthalmology is an ophthalmology treatment firm. It has more than 30 years of operating experience in ophthalmic hospitals. The group has strong technical strength, with more than 2,000 employees including professors, researchers, chief physicians and deputy chief physicians, as well as more than 100 medical clinics composed of clinical professors.

U-dental is a Chinese dental chain clinic operator that offers services such as dental implanting, orthodontic treatment, root canal therapy, periodontal treatment, and cosmetic dentistry.

KingstronBio manufactures artificial heart valves and annuloplasty rings.